Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study - Concepedia

Concepedia

Publication | Open Access

Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study

DOI Full Paper Access

70

Citations

20

References

2021

Year

Shinichiro Shinzaki, Katsuyoshi Matsuoka, Hiroki Tanaka, Fuminao Takeshima, Shingo Kato, Takehiro Torisu, Yuki Ohta, Kenji Watanabe, Shirô Nakamura, Naoki Yoshimura,

Journal of Gastroenterology

Abstract

Serum LRG is a useful biomarker of endoscopic activity both in CD and UC during the adalimumab treatment.

References

	Year	Citations

Page 1